Interleukin-6 and use of social support in gynecologic cancer patients

  • Susan K. Lutgendorf
  • Barrie Anderson
  • Joel I. Sorosky
  • Richard E. Buller
  • David M. Lubaroff


Interleukin-6 (IL-6) is related to disease progression in ovarian and cervical cancers and is associated with abnormal endometrial cell growth. IL-6 is also involved in the stress response and depression. We examined relationships among distress, use of social support, IL-6, clinical status, and disability in gynecologic cancer patients. A sample of 21 gynecologic cancer patients with early stage or regionally advanced disease who had not yet received initial treatment and 33 healthy controls completed psychosocial assessments and had early morning blood draws. This was done presurgery for patients. Clinical and functional status of patients was assessed at 1 year. IL-6 was significantly higher among patients than among controls. Among patients, seeking instrumental support at diagnosis was associated with lower concurrent IL-6, better clinical status, and less disability at 1 year. Distress was not correlated with these outcome measures, and IL-6 did not mediate the effects of social support on these outcomes. These findings suggest that the ways patients cope with stress of cancer may be associated with a cytokine that is involved in tumor progression in gynecologic cancers and with clinical variables at 1 year.

Key words

IL-6 seeking instrumental social support distress gynecologic cancer 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aiken, L.S., & West, S.G. (1991). Multiple regression: Testing and interpreting interactions. Newbury Park, CA: Sage.Google Scholar
  2. American Cancer Society. (1999). Cancer facts and figures—1999. Atlanta, GA: Author.Google Scholar
  3. Andersen, B., Anderson, B., & de Prosse, C. (1989). Controlled prospective longitudinal study of women with cancer: II. Psychological Outcomes. Journal of Consulting and Clinical Psychology, 57, 692–697.PubMedCrossRefGoogle Scholar
  4. Andersen, B. L., Farrar, W. B., Golden-Kreutz, D., Kutz, L. A., MacCallum, R., Courtney, M.E. & Glaser, R. (1998). Stress and immune responses after surgical treatment for regional breast cancer. Journal of the National Cancer Institute, 90, 30–36.PubMedCrossRefGoogle Scholar
  5. Andersen, B., Kiecolt-Glaser, J., & Glaser, R. (1994). A biobehavioral model of cancer stress and disease course. American Psychologist, 49, 389–404.PubMedCrossRefGoogle Scholar
  6. Baron, R., Cutrona, C, Russell, D., & Lubaroff, D. (1990). Social support and immune function among spouses of cancer patients. Journal of Personality and Social Psychology, 39, 344–352.CrossRefGoogle Scholar
  7. Baron, R.M., & Kenney, D. A. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51, 1173–1182.PubMedCrossRefGoogle Scholar
  8. Berek, J. S., Chung, C, Kaldi, K., Watson, H. M., Knox, R. M., & Martinez-Maza, O. (1991). Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. American Journal of Obstetrics & Gynecology, 164, 1038–1042.Google Scholar
  9. Berman, W. H., & Turk, D. C. (1981). Adaptation to divorce: Problems and coping strategies. Journal of Marriage & the Family, 43, 179–189.CrossRefGoogle Scholar
  10. Billings, A. G., & Moos, R. H. (1984). Coping, stress, and social resources among adults with unipolar depression. Journal of Personality & Social Psychology, 46, 877–891.CrossRefGoogle Scholar
  11. Carver, C., Sheier, M., & Weintraub, J. (1989). Assessing coping strategies: A theoretically based approach. Journal of Personality and Social Psychology, 56, 267–283.PubMedCrossRefGoogle Scholar
  12. Chopra, V., Dinh, T. V., & Hannigan, E. V. (1997). Serum levels of interleukins, growth factors and angiotensin in patients with endometrial cancer. Journal of Cancer Research and Clinical Oncology, 123, 167–172.PubMedGoogle Scholar
  13. Chopra, V., Dinh, T. V., & Hannigan, E. (1998). Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer. Cancer Investigation, 16, 152–159.PubMedCrossRefGoogle Scholar
  14. Cohen, S., & Wills, T. A. (1985). Stress, social support, and the buffering hypothesis. Psychological Bulletin, 98, 310–357.PubMedCrossRefGoogle Scholar
  15. Corney, R. H., Everett, H., Howells, A., & Crowther, M. E. (1992). Psychological adjustment following major gynaecological surgery for carcinoma on the cervix and vulva. Journal of Psychosomatic Research, 36, 561–568.PubMedCrossRefGoogle Scholar
  16. Costanza, R. S., Derlega, V. J., & Winstead, B. A. (1988). Positive and negative forms of social support: Effects of conversational topics on coping with stress among same-sex friends. Journal of Experimental Social Psychology, 24, 182–193.CrossRefGoogle Scholar
  17. Curran, S. L., Andrykowski, M. A., & Studts, J. L. (1995). Short form of the profile of mood states (POMS-SF): Psychometric information. Psychological Assessment, 7, 80–83.CrossRefGoogle Scholar
  18. DeRijk, R., Michelson, D., Karp, B., Petrides, J., Galliven E., Deuster, P., Paciotti, G., Gold, P.W., & Sternberg, E.M. (1997). Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1b (IL-1b), Il-6, and tumor necrosis factor (TNF-a) production in humans: High sensitivity of TNFa and resistance of IL-6. Journal of Clinical Endocrinology Metabolism, 82, 1–10.CrossRefGoogle Scholar
  19. Ershler, W. B. (1993). Interleukin-6: A cytokine for gerontologists. Journal of the American Geriatric Society, 41, 176–181.Google Scholar
  20. Eustace, D., Han, X., Gooding, R., Rowbottom, A., Riches, P., & Heyderman, E. (1993). Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro. Gynecologic Oncology, 50, 15–19.PubMedCrossRefGoogle Scholar
  21. Frankenhaeuser, M. (1991). The psychophysiology of workload, stress and health: Comparison between the sexes. Annals of Behavioral Medicine, 13, 197–204.Google Scholar
  22. Frommberger, U. H., Bauer, J., Haselbauer, P., Fraulin, A., Riemann, D., & Berger M. (1997). Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. European Archives of Psychiatry & Clinical Neuroscience, 247, 228–33.CrossRefGoogle Scholar
  23. Funch, D. P., & Mettlin, C. (1982). The role of support in relation to recovery from breast surgery. Social Science and Medicine, 16, 19–98.CrossRefGoogle Scholar
  24. Helgeson, V. S., & Cohen, S. (1996). Social support and adjustment to cancer: Reconciling descriptive, correlational, and intervention research. Health Psychology, 15, 135–148.PubMedCrossRefGoogle Scholar
  25. Herbert, T. B., & Cohen, S. (1993). Depression and immunity: a meta-analytic review. Psychology Bulletin, 113, 472–486.CrossRefGoogle Scholar
  26. House, J. S., & Kahn, R.L. (1985). Measures and concepts of social support. In S. Cohen & L. Syme (Eds.), Social support and health (pp.83–108).Orlando, FL: Academic.Google Scholar
  27. House, J. S., Landis, K. R., & Umberson, D. (1988). Social relationships and health. Science, 241, 540–545.PubMedCrossRefGoogle Scholar
  28. Kiecolt-Glaser, J. K., Malarkey, W. B., Chee, M., Newton, T., Cacioppo, J. T., Mao, H., & Glaser, R. (1993). Negative behavior during marital conflict is associated with immunological down-regulation. Psychosomatic Medicine, 55, 395–409.PubMedGoogle Scholar
  29. Kuhn, C. (1989). Adrenocortical and gonadal steroids in behavioral cardiovascular medicine. In N. Schneiderman, S. Weiss, & P. Kaufmann (Eds.), Handbook of research methods in cardiovascular behavioral medicine (pp. 185–204). New York: Plenum.Google Scholar
  30. Lepore, S. J., Allen, K. A., & Evans, G. W. (1993). Social support lowers cardiovascular reactivity to an acute stressor. Psychosomatic Medicine, 55, 518–524.PubMedGoogle Scholar
  31. Levy, S. M., Heberman, R. B., Lee, J., Whiteside, T., Kirkwood, J., &McFeeley, S. (1990). Estrogen receptor concentration and social factors as predictors of natural killer cell activity in early-stage breast cancer patients: Confirmation of a model. Natural Immunity and Cell Growth Regulation, 313–324.Google Scholar
  32. Lutgendorf, S. K., Garand, L., Buckwalter, K, C., Tripp Reimer, T., Hong, S-Y., & Lubaroff, D. (1999). Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. Journals of Gerontology: Medical Sciences, 54A, M1-M6.Google Scholar
  33. Maes, M., Bosnians, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., & Neels, H. (1997). Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytoldne, 9, 853–858.Google Scholar
  34. Mastorakos, G., Chrousos, G. P., & Weber, J. S. (1993). Recombinant Interleukin-6 activates the hypo-thalamic pituitary adrenal axis in humans. Journal of Clinical Endocrinology Metabolism, 77, 1690–1694.PubMedCrossRefGoogle Scholar
  35. Mitchell, G. W., & Glicksman, A. S. (1977). Cancer patients: Knowledge and attitudes. Cancer, 40, 61–66.PubMedCrossRefGoogle Scholar
  36. Neises, M., Nebe, T., Schiller, A., Ditz, S., Wischnik, A., & Melchert, F. (1995). Coping with illness/quality of life and immunologic parameters of patients with breast carcinoma and benign tumors. Gynäkologisch-Geburtshilfliche Rundschau, 35(Suppl. 1), 166–171.PubMedCrossRefGoogle Scholar
  37. Obata, N. H., Tamakoshi, K., Shibata, K., Kikkawa, F., & Tomoda, Y. (1997). Effects of interleukin-6 on in vitro cell attachment, migration, and invasion of human ovarian carcinoma. Anticancer Research, 17, 337–342.PubMedGoogle Scholar
  38. Peck, A., & Bowland, J. (1977). Emotional reactions to radiation treatment. Cancer, 40, 180–184.PubMedCrossRefGoogle Scholar
  39. Plante, M., Rubin, S. C., Wong, G. Y., Federici, M. G., Finstad, C. L., & gastl, G. A. (1994). Interleukin-6 level in serem and ascites as a prognostic factor in patients with epithehal ovarian cancer. Cancer, 73, 1882–1888.PubMedCrossRefGoogle Scholar
  40. Reynaert, C., Janne, P., Bosly, A., Staquet, P., Zdanowicz, N., Vause, M., Chatelain, B., & Lejeune, D. (1995). From health locus of control to immune control: Internal locus of control has a buffering effect on natural killer cell activity decrease in major depression. Acta Psychiatrica Scandinavica, 92, 294–300.PubMedCrossRefGoogle Scholar
  41. Salaffi, F., Cavalieri, F., Nolli, M., & Ferraccioli, G. (1991). Analysis of disability in knee osteoarthritis: Relationship with age and psychological variables but not radiographic score. Journal of Rheumatology, 18, 1581–1586.PubMedGoogle Scholar
  42. Scambia, G., Testa, U., Benedetti, P., Foti, E., Nartucci, R., Gadducci, A., Perillo, A., Facchini, V., Peschle, C., & Mancuso, S. (1995). Prognostic significance of IL-6 serum levels in patients with ovarian cancer. British Journal of Cancer, 71, 352–356.Google Scholar
  43. Seeman, T. E., Berkman, L. F., Blazer, D., & Rowe, J. W. (1994). Social ties and support and neuroendocrine function: The MacArthur studies of successful aging. Annals of Behavioral Medicine, 16, 95–106.Google Scholar
  44. Shacham, S. (1983). A shorterned version of the Profile of Mood States. Journal of Personality Assessment, 47, 305–306.PubMedCrossRefGoogle Scholar
  45. Sluzewska, A., Rybakowski, J., Laciak, M., Mackiewicz, A., Sobieska, M., & Wiktorowicz, K. (1995). Interleukin-6 levels in depressed patients before and after treatment with fluoxetine. Annals the New York Academy of Sciences, 762, 474–476.CrossRefGoogle Scholar
  46. Uchino, B. N, Cacioppo, J. T., & Kiecolt-Glaser, J. K. (1996). The relationship between social support and physiological processes: A review with emphasis on underlying mechanisms and implications for health. Psychological Bulletin, 119, 488–531.PubMedCrossRefGoogle Scholar
  47. van Gool, J., van Vugt, Ft., Helle, M. & Aarden, L. A. (1990). The relation among stress, adrenalin, interleukin-6 and acute phase proteins in the rat. Clinical Immunology and Immunopathology, 57, 200–210.PubMedCrossRefGoogle Scholar
  48. Van Snick, J. (1990). Interleukin-6: An overview. Annual Review of Immunology, 8, 253–278.PubMedCrossRefGoogle Scholar
  49. Zarmakoupis, P. N., Rier, S. E., Maroulis, G. B., & Becker, J. L. (1995). Inhibition of human endometrial stromal cell proliferation by interleukin-6. Human Reproduction, 10, 2395–9.PubMedGoogle Scholar
  50. Zhou, D., Kusnecov, A., Shurin, M., DePaoli, M., & Rabin, B. (1993). Exposure to physical and psychological stressors elevates plasma interleukin-6. Relationship to the activation of hypothalamic-pitu-itary-adrenal axis. Endocrinology, 133, 2523–2530.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Behavioral Medicine 2000

Authors and Affiliations

  • Susan K. Lutgendorf
    • 1
  • Barrie Anderson
    • 2
  • Joel I. Sorosky
    • 2
  • Richard E. Buller
    • 2
    • 3
  • David M. Lubaroff
    • 4
  1. 1.Department of Psychology, E11 Seashore HallUniversity of IowaIowa City
  2. 2.Department of Obstetrics and Gynecology, Division of Gynecologic OncologyUniversity of IowaIowa CityUSA
  3. 3.Department of PharmacologyUniversity of IowaIowa CityUSA
  4. 4.Department of Urology and MicrobiologyUniversity of IowaIowa CityUSA

Personalised recommendations